B. Prager

Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost–effectiveness analysis

E. Joura, X. Bresse, C. Goergen, 2014, Expert review of pharmacoeconomics & outcomes research.

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

E. Joura, L. Boiron, N. Largeron, 2016, BMC Infectious Diseases.

Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria.

E. Joura, L. Boiron, N. Largeron, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.